Nicholas Virca
Chief Executive Officer at Hedgepath LLC
Net worth: 610 926 $ as of 2024-03-30
Profile
Nicholas Jon Virca is currently the President, Chief Executive Officer & Director at Hedgepath LLC since 2012.
Previously, he held the position of President & Chief Executive Officer at Mast Therapeutics, Inc. from 1997 to 2004.
He also served as the President & Chief Executive Officer at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Additionally, he worked as a Director at Panoptix Events from 2007 to 2017 and as a Director at Diametrix Detectors, Inc. from 1991 to 1997.
Furthermore, he held the role of Vice President-Global Biotechnology at Pall Corp.
and Cytiva US LLC from 2005 to 2008.
Lastly, he served as the Chief Operating Officer at LamdaGen Corp.
from 2008 to 2012.
Mr. Virca obtained his undergraduate degree from Youngstown State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-28 | 8,727,519 ( 5.07% ) | 610 926 $ | 2024-03-30 |
Nicholas Virca active positions
Companies | Position | Start |
---|---|---|
Hedgepath LLC | Chief Executive Officer | 2012-03-31 |
Former positions of Nicholas Virca
Companies | Position | End |
---|---|---|
INHIBITOR THERAPEUTICS, INC. | Chief Executive Officer | 2022-12-12 |
Panoptix Events
Panoptix Events Miscellaneous Commercial ServicesCommercial Services Panoptix Events operates as an event planning agency. It helps small and mid-size organizations to achieve maximum results from their events and tradeshows. The firm’s services include marketing mix strategy, budgeting, planning, sourcing ideas and logistics management. The company is headquartered in Henderson, NV. | Director/Board Member | 2016-12-31 |
LamdaGen Corp.
LamdaGen Corp. Miscellaneous Commercial ServicesCommercial Services LamdaGen Corp. develops proprietary biosensors and instruments. Its products include Plasmonic ELISA, LightPath S4 and LSPR sensors. The firm's products include nano-biosensors for in vitro diagnostics, including central laboratory based and point of care testing for human, veterinary and farm animal health. Its nanotechnology platforms are also purposed for additional scientific applications and products including drug discovery and development and life science research. The company was founded by Randolph C. Storer in 2004 and is headquartered in Menlo Park, CA. | Chief Operating Officer | 2012-03-31 |
PALL CORPORATION | Corporate Officer/Principal | 2007-12-31 |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Corporate Officer/Principal | 2007-12-31 |
Training of Nicholas Virca
Youngstown State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INHIBITOR THERAPEUTICS, INC. | Health Technology |
Private companies | 7 |
---|---|
Pall Corp.
Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Hedgepath LLC | |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Health Technology |
LamdaGen Corp.
LamdaGen Corp. Miscellaneous Commercial ServicesCommercial Services LamdaGen Corp. develops proprietary biosensors and instruments. Its products include Plasmonic ELISA, LightPath S4 and LSPR sensors. The firm's products include nano-biosensors for in vitro diagnostics, including central laboratory based and point of care testing for human, veterinary and farm animal health. Its nanotechnology platforms are also purposed for additional scientific applications and products including drug discovery and development and life science research. The company was founded by Randolph C. Storer in 2004 and is headquartered in Menlo Park, CA. | Commercial Services |
Panoptix Events
Panoptix Events Miscellaneous Commercial ServicesCommercial Services Panoptix Events operates as an event planning agency. It helps small and mid-size organizations to achieve maximum results from their events and tradeshows. The firm’s services include marketing mix strategy, budgeting, planning, sourcing ideas and logistics management. The company is headquartered in Henderson, NV. | Commercial Services |
Diametrix Detectors, Inc. |
- Stock Market
- Insiders
- Nicholas Virca